By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat and prevent disease worldwide.
Pay Range:
This position is based in Minneapolis, MN or available remotely within the United States with travel required as needed.
About the Role
Bio-Techne is undergoing a transformation—shifting from a product-led to an application-driven operating model. As part of this shift, we are launching the Target Analysis Business Unit, focused on how scientists analyze and validate biological targets across research and translational workflows. The Senior Director, Target Analysis BU Leader will lead this new application-aligned business unit, bringing together our Antibody and Licensing & Commercial Supply (LCS) portfolios to drive focused growth in Spatial Biology, Immunoassays, and LCS opportunities in life science, diagnostic, and therapeutic markets.
This is a high-impact role with full business ownership—responsible for shaping application strategies, driving commercial success through strategic partnerships, and transforming how we serve our customers across key end markets.
Key Responsibilities
Application Strategy & Market Focus
Define and lead application-centric strategies for:
Spatial Biology (IHC, multiplex imaging, high-plex platforms)
Immunoassays (ELISA, multiplex, Olink, Luminex, etc.)
Licensing & Commercial Supply (LCS) in life science, diagnostic, and therapeutic markets
Identify unmet market needs and shape portfolio roadmaps, workflow positioning, and value propositions that win in high-growth and emerging segments.
Collaborate with Product Marketing and Commercial teams to define go-to-market (GTM) strategies, including bundling, segmentation, targeting, and messaging.
Business Ownership & Execution
Serve as the business owner responsible for delivering revenue growth and profitability targets.
Lead the Product Management team, ensuring sharp prioritization and strong lifecycle management across the Antibody and LCS portfolios.
Operate in a matrixed environment—partnering closely with:
Centralized R&D
Commercial Sales Teams (including OEM and strategic accounts)
Product Marketing
Supply Chain and Operations
LCS Growth Engine
Build and execute a strategy for sustained growth in Licensing & Commercial Supply across research, diagnostics, and therapeutic applications.
Deepen relationships with OEM customers through improved commercial offerings, technical support, and operational execution.
Identify and grow new LCS accounts in adjacent and emerging market segments.
Key Qualifications
8+ years of experience in life science tools, diagnostics, or reagent-based businesses, including experience in product management, commercial strategy, or business unit leadership.
Strong domain knowledge in antibodies, spatial biology, and/or immunoassays—with demonstrated ability to define customer-led growth strategies.
Experience working across LCS/OEM business models and navigating research and regulated markets.
Ability to lead cross-functional teams and drive strategy through influence in a matrixed environment.
Data-driven, commercially minded, and comfortable with P&L ownership.
What Does Success Look Like?
Application Strategy in Action: Clear, focused strategies driving momentum in Spatial Biology, Immunoassay, and LCS segments. Our antibodies and bundles are clearly positioned in workflows, and customers see us as a go-to partner.
LCS is Growing with Discipline: Strategic accounts are expanding, new OEM deals are being closed, and execution is improving through tighter commercial and operational alignment.
GTM is Cohesive and Effective: Partnering with marketing and sales, you’ve brought clarity to how we go to market by segment and region. Targeted campaigns and new positioning are showing up in the field and moving the needle.
Product Management is Leading: The team is engaged, empowered, and focused on delivering business impact. Roadmaps are aligned to market needs, and the BU is delivering against financial commitments.
Trusted Leadership: You’re seen as a key voice helping lead Bio-Techne’s cultural evolution—championing cross-functional collaboration, customer focus, and performance accountability.
Why Join Bio-Techne:
- We offer competitive insurance benefits starting on day one: medical, dental, vision, life, short-term disability, long-term disability, pet, and legal and ID shield.
- We invest in our employees’ financial futures through 401k plans, an employee stock purchase plan (ESPP), Health Saving Account (HSA), Flexible Spending Account (FSA), and Dependent Care FSA.
- We empower our employees develop their careers through mentorship, promotional opportunities, training and development, tuition reimbursement, internship programs, and more.
- We offer employee resource groups, volunteer paid time off, employee events, and charity drives to build a culture of caring and belonging.
- We offer an accrued leave policy with paid holidays, paid time off, and paid parental leave.
- We foster a culture of empowerment and innovation, where employees feel valued and encouraged to bring their new ideas to the table.
Bio-Techne is an E-Verify Employer in the United States.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran.
To protect the interests of all, Bio-Techne will not accept unsolicited resumes from any source other than a candidate application. Any unsolicited resumes sent to Bio-Techne will be considered Bio-Techne property.
Top Skills
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering
